Colchicine--what is its place in the management of acute gout?
This series of articles facilitated by the Cochrane Musculoskeletal Group (CMSG) aims to place the findings of recent Cochrane musculoskeletal reviews in a context immediately relevant to general practitioners. This article considers the place of colchicine in the management of acute gout.
Winzenberg
Tania
T
Menzies Research Institute, University of Tasmania. tania.winzenberg@utas.edu.au
Zochling
Jane
J
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D001315:Australia / Q000453:epidemiology; D003078:Colchicine / Q000009:adverse effects / Q000627:therapeutic use*; D005194:Family Practice / Q000706:statistics & numerical data; D006073:Gout / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D006074:Gout Suppressants / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D003078:Colchicine